OU College of Medicine researcher earns grant to study ‘chemo brain’
Anna Csiszar, M.D., Ph.D., a researcher in the Center for Geroscience and Healthy Brain Aging and a professor in the University of Oklahoma College of Medicine, has been awarded a $1.6 million federal grant to study a promising new hypothesis to address “chemo brain.”
Chemo brain, formally known as chemotherapy-related cognitive impairment, which can include symptoms such as difficulty focusing, processing information, learning new tasks, and planning or making decisions. “It’s very frustrating for cancer survivors to experience these long-term side effects,” Csiszar said.
Csiszar, who received the grant from the National Cancer Institute, focuses on aging and age-related cognitive impairment in her research lab.
To be considered for this column, please email achievement announcements and photos to LLynn@Oklahoman.com.